K-numberK252167
Device nameEnhanced Silver Gelling Fiber Dressing (OTC) Extra Enhanced Silver Gelling Fiber Dressing (Prescription)
ApplicantQingdao Bright Moon Biomedical Materials Co., Ltd.
Product codeFRO
Device classClass U
Decision dateDec 19, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Enhanced Silver Gelling Fiber Dressing is a soft, sterile, conformable wound dressing made of sodium carboxymethyl cellulose fibers with 1.2% ionic silver that absorbs wound fluid, creates a moist gel environment, and releases silver ions to reduce bacterial growth for up to seven days. It is available in both over-the-counter formulation for minor wounds (abrasions, lacerations, minor cuts, minor burns) and prescription formulation for more serious wounds including diabetic ulcers, pressure ulcers, surgical wounds, traumatic wounds, and bleeding-prone wounds.

Technological characteristics

The subject device contains sodium carboxymethyl cellulose fibers with strengthening polyester layer and 1.2% ionic silver, compared to the predicate which uses Hydrofiber™ with 1.2% ionic silver plus EDTA and benzethonium chloride. Both achieve similar liquid absorbency (subject: 20.55 g/100cm², predicate: 20.26 g/100cm²), maintain moist wound healing environments, inhibit bacterial growth for seven days, are sterilized by radiation at SAL 10⁻⁶, and meet identical biocompatibility requirements per ISO 10993-1.

Test standards cited

Biocompatibility testing per ISO 10993-1 (cytotoxicity, sensitization, irritation, acute/subacute systemic toxicity, implantation, material-mediated pyrogenicity); liquid absorbency per EN 13726-1-2002; loss on drying per USP <731>; pH per USP <791>; antimicrobial efficacy per AATCC 100-2019.

Substantial equivalence argument

The subject device is substantially equivalent because it demonstrates the same intended uses, mode of action, single-use design, antibacterial duration, sterilization method, and biocompatibility profile as the predicate AQUACEL Ag+ EXTRA. Performance bench testing confirms the device meets all design specifications and complies with applicable standards, demonstrating it is as safe and effective as the predicate device despite minor differences in component formulation.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →